Pricing Log in Create free account

Enliven Therapeutics, Inc. (ELVN) vs Precigen, Inc. (PGEN)

Enliven Therapeutics, Inc. and Precigen, Inc. are both Biotechnology companies. Enliven Therapeutics, Inc. is the larger, with a market value of $2.9B against $2.6B — 1.1× the size. Enliven Therapeutics, Inc. has the higher net margin (0.00% vs −392.8%) and the higher return on invested capital (0.00% vs −24.9%). Across the 14 metrics below, Enliven Therapeutics, Inc. leads on 12 and Precigen, Inc. on 2.

Valuation

Metric ELVN PGEN Biotechnology median
P/E n/m n/m 8.50
P/S n/m 26.44 9.71
P/B 2.76 52.01 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 27.25 9.21
Earnings yield (4.47%) (16.22%) (33.15%)
Free cash flow yield (2.71%) (5.08%) (25.50%)

Profitability

Metric ELVN PGEN Biotechnology median
Gross margin 0.00% 90.67% 65.16%
Operating margin 0.00% (46.08%) 0.00%
Net margin 0.00% (392.81%) 0.00%
Free cash flow margin 0.00% (134.42%) 0.00%
Return on equity (15.31%) (9,907.46%) (56.36%)
Return on assets (14.98%) (247.40%) (48.04%)
Return on invested capital 0.00% (24.87%) 0.00%

Growth

Metric ELVN PGEN Biotechnology median
Revenue growth (TTM) — 1,875.05% 6.02%
EPS growth (last fiscal year) 3.17% (191.49%) 30.26%
Revenue growth, 5-year CAGR — (21.26%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ELVN PGEN Biotechnology median
Debt to equity 0.00 2.15 0.00
Current ratio 64.07 4.58 4.72
Net debt to EBITDA 3.87 0.04 0.96

Dividend

Metric ELVN PGEN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ELVN PGEN Biotechnology median
Market cap 2.88b 2.58b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack